Rathman Lisa, Repoley Jill, Delgado Sherri, Trupp Robin
Heart Failure Program, The Heart Group, Lancaster, Pennsylvania 17603, USA.
J Cardiovasc Nurs. 2008 Mar-Apr;23(2):159-68. doi: 10.1097/01.JCN.0000305077.28528.92.
Heart failure (HF) is a complex and costly disease process associated with high morbidity and mortality. Implanted cardiac rhythm management devices are increasingly used in the HF population to provide therapies such as protection from sudden death and cardiac resynchronization therapy. Device-based diagnostic monitoring provides clinicians with information that can assist in identifying patients at risk for HF decompensation and subsequent hospitalization. This article will review the evidence for using diagnostic information from cardiac rhythm management devices in the management of HF patients. Future advanced monitoring devices will also be discussed.
心力衰竭(HF)是一种复杂且代价高昂的疾病过程,与高发病率和死亡率相关。植入式心脏节律管理设备越来越多地用于心力衰竭患者群体,以提供诸如预防猝死和心脏再同步治疗等疗法。基于设备的诊断监测为临床医生提供信息,有助于识别有心力衰竭失代偿和随后住院风险的患者。本文将综述在心力衰竭患者管理中使用来自心脏节律管理设备的诊断信息的证据。还将讨论未来的先进监测设备。